{
    "output": [
        [
            "Novo Nordisk",
            "ORG",
            "Bid",
            "Ablynx",
            "ORG"
        ],
        [
            "Ablynx",
            "ORG",
            "Reject",
            "Novo Nordisk",
            "ORG"
        ],
        [
            "Novo Nordisk",
            "ORG",
            "Operate_In",
            "Biotech Industry",
            "SECTOR"
        ],
        [
            "Ablynx",
            "ORG",
            "Specialize",
            "Nano-bodies",
            "CONCEPT"
        ],
        [
            "Novo Nordisk",
            "ORG",
            "Interest",
            "Ablynx",
            "ORG"
        ],
        [
            "Novo Nordisk",
            "ORG",
            "Pay",
            "Ablynx",
            "ORG",
            "CVR"
        ],
        [
            "Novo Nordisk",
            "ORG",
            "New_CEO",
            "Lars Fruergaard Jorgensen",
            "PERSON"
        ],
        [
            "Novo Nordisk",
            "ORG",
            "Discuss",
            "Global Blood Therapeutics",
            "ORG"
        ],
        [
            "Novo Nordisk",
            "ORG",
            "Regret",
            "Ablynx",
            "ORG"
        ],
        [
            "Ablynx",
            "ORG",
            "Partner",
            "Pharmaceutical Companies",
            "ORG"
        ],
        [
            "Ablynx",
            "ORG",
            "Experimental_Drug",
            "Caplacizumab",
            "PRODUCT"
        ],
        [
            "Novo Nordisk",
            "ORG",
            "Line-Up",
            "Blood Products",
            "PRODUCT"
        ],
        [
            "Novo Nordisk",
            "ORG",
            "Sales",
            "Haemophilia Market",
            "SECTOR"
        ],
        [
            "Novo Nordisk",
            "ORG",
            "Biopharmaceutical_Treatments",
            "Biopharma",
            "SECTOR"
        ],
        [
            "Novo Nordisk",
            "ORG",
            "Chief_Financial_Officer",
            "Jesper Brandgaard",
            "PERSON"
        ],
        [
            "Novo Nordisk",
            "ORG",
            "Potential_Takeover",
            "Global Blood Therapeutics",
            "ORG"
        ],
        [
            "Novo Nordisk",
            "ORG",
            "Counter_Proposals",
            "Other Bidders",
            "ORG"
        ],
        [
            "Belgium",
            "GPE",
            "Thriving_Biotech_Scene",
            "Biotech Industry",
            "SECTOR"
        ],
        [
            "Ablynx",
            "ORG",
            "Share_Price",
            "29 Euros",
            "ECON_INDICATOR"
        ],
        [
            "Ablynx",
            "ORG",
            "Share_Price",
            "36 Euros",
            "ECON_INDICATOR",
            "Upside_Scenario"
        ],
        [
            "Ablynx",
            "ORG",
            "Products",
            "Medical_Trials",
            "EVENT"
        ],
        [
            "Ablynx",
            "ORG",
            "Products",
            "Diseases",
            "CONCEPT"
        ],
        [
            "Evercore",
            "ORG",
            "Advise",
            "Novo Nordisk",
            "ORG"
        ],
        [
            "JP_Morgan",
            "ORG",
            "Work",
            "Ablynx",
            "ORG"
        ]
    ]
}